Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
Search or
𝛼
SK
SIGN UP
SIGN IN
Sign in with Google. Opens in new tab
bullish
Medlive Technology
Watchlist
Medlive - High Conviction Update 2022
Equity Bottom-Up
372 Views
05 Apr 2022 06:18
Medlive is currently trading at a FY2 EV/Revenue of 0.97x and we think Medlive’s shares are extremely cheap at the current valuation and offers a good entry point.
SUMMARY
(Sign Up to Access)
Full Insight
(Paid Plans Only, 4-minute read)
Related Insights
More »
Loading
Trending Collections
More »
Index Rebalance
Japan
Sell / Short Ideas
Event-Driven
South Korea
Tech Hardware and Semiconductor Research
Equity Bottom-Up
Singapore
India
Japan Small Cap Growth
Trending Insights
More »
Hang Seng Indexes: Announcement Tomorrow; Potential Changes & Updated Flows
Daiichi Sankyo Placement - US$1.2bn Deal but Momentum Isn’t the Best, Last Deal Didn’t Do Well
US Government May Acquire Equity Stakes in Samsung Electronics and TSMC
UK CPI Trend Extends Excess In July
HK-Listed Apparel & Footwear Screener Aug 2025: Lever Style (1346 HK) Conference Call
Top Unpaywalled Insights
More »
India-China Economic Relations: Navigating Massive Imbalances and Strategic Dependencies
Kyivstar (KYIV US): Structural Long – From Ukraine’s Resilience to Renewal; Uklon Embedded Value
How to Own Lenovo at a Discount: BUY Legend Holdings Corp (3396 HK)
Institutions Are Coming for Bitcoin — UTXO’s Loren Asmus Explains How
Curator's Cut: Singapore Unlocks Value, India’s Jewellery Caution & Taiwan's Top ETF's Rebalance
Discussions
(Paid Plans Only)
Price Chart
(Sign Up to Access)
Insight Stream
Takeda 4QFY22: Top Line Expands and Pipeline Development Progresses Despite OP Drop
12 May 2022
OneConnect Files for Secondary Listing; Not Yet a Convincing Story
07 Apr 2022
Takeda Strengthens Rare Disease Portfolio Through Tie-Ups with Gene Therapy Developers
06 Apr 2022
Medlive - High Conviction Update 2022
05 Apr 2022
M3: Covid Related Trials and Vaccination Programs Drive Earnings; Core Business Growth Slowing Down
02 Feb 2022
2022 High Conviction – Medlive: Key Beneficiary of Digital Healthcare Marketing in China
08 Dec 2021
Medlive IPO: Thoughts on First Day Trading
14 Jul 2021
Top
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.56.3
x